Literature DB >> 31179516

Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study.

Jihene Bettaieb1,2,3,4, Anissa Chouikha5,6,7, Marwa Khedhiri8,2,3, Ghassen Kharroubi1,2,3,4, Malek Badreddine1,4, Nabil Bel Hadj Hmida1,2,3, Adel Gharbi1,2,3, Walid Hammemi8,3, Amel Sadraoui8,3, Ahlem Ben Yahia8,3, Zina Meddeb8,3, Afif Ben Salah1,2,3,4,9, Henda Triki8,2,3,4.   

Abstract

This study aimed to assess the seroprevalence, viraemia and genotype distribution of hepatitis C virus (HCV) in a region in Central-West Tunisia. A door-to-door cross-sectional study was conducted on a randomly selected sample. A total of 3178 individuals aged 5 to 74 years and members of 935 families were investigated. Seroprevalence of HCV was assessed using ELISA tests. The viral load was determined by real-time RT-PCR, and HCV genotyping was conducted by amplification and sequencing in the NS5b genomic region. The global prevalence of HCV antibodies was 3.32% (95% confidence interval [CI]: 2.72-4.00). It was significantly higher in women: 4.47% vs. 2.16% in men, p = 0.001. Seroprevalence increased with age, and the highest rates were found in the 50- to 59-year-old age group (12.90%, 95% CI: 9.45-16.86), suggesting a cohort effect with very low contribution of intrafamilial transmission. Genotyping showed a predominance of subtype 1b (84.6%), with cocirculation of subtypes 2c (9.6%), 1a (1.9%), 1d (1.9%) and 2k (1.9%), similar to the previously reported genotype distribution in Tunisia and with no genetic clusters specific to the study region. These results indicate a higher endemicity of HCV infection when compared to the previously reported nationwide surveillance data. This study provides valuable data that can contribute to current strategies to eliminate hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31179516     DOI: 10.1007/s00705-019-04308-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective study.

Authors:  Anissa Chouikha; Marwa Khedhiri; Hatem Triki; Walid Hammemi; Amel Sadraoui; Henda Touzi; Ahlem Ben Yahia; Amel Chtourou; Saba Gargouri; Lamia Feki Ben Rajah; Hela Hakim Karray; Henda Triki
Journal:  Arch Virol       Date:  2021-01-04       Impact factor: 2.574

2.  Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS).

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Mohammadreza Naghipour; Soheil Hassanipour; Sara Yeganeh; Masood Sepehrimanesh; Mohammad Fathalipour
Journal:  BMC Res Notes       Date:  2021-02-10

3.  Hepatitis C in Tunisia from 1991 to 2019: A systematic review.

Authors:  Marwa Khedhiri; Hatem Triki; Henda Triki
Journal:  Tunis Med       Date:  2021-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.